PNV has been killed by ASX200 removal and a wider bio-tech sell down:
I expect a bounce to $2 by year end on positive free cash flow and 50%+ growing revenues and the mkt selling pressures subsided. $3+ by June 2023 because it will be back in the ASX200, a rising stock at the tail end of the ASX200 mkt caps where stocks remain mostly on their knees amidst a stuttering global economy and aimless central banks all over the place with inflation up and down and money markets in strife.
PNV has been killed by ASX200 removal and a wider bio-tech sell...
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.04 |
Change
0.055(2.77%) |
Mkt cap ! $1.409B | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $1.99 | $3.142M | 1.550M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1009 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.04 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |